撤回：肝细胞癌脑转移的危险因素。
Retracted: Risk Factors for Brain Metastasis of Hepatocellular Carcinoma.
作者信息
Healthcare Engineering Journal Of
出版信息
J Healthc Eng. 2023 Sep 20;2023:9783892. doi: 10.1155/2023/9783892. eCollection 2023.
Abstract
[This retracts the article DOI: 10.1155/2022/7848143.].
摘要
[本文撤回文章DOI: 10.1155/2022/7848143。]
相似文献
1
Retracted: Risk Factors for Brain Metastasis of Hepatocellular Carcinoma.撤回：肝细胞癌脑转移的危险因素。
J Healthc Eng. 2023 Sep 20;2023:9783892. doi: 10.1155/2023/9783892. eCollection 2023.
2
Retracted: Midazolam Suppresses Hepatocellular Carcinoma Cell Metastasis and Enhances Apoptosis by Elevating miR-217.撤回：咪达唑仑通过上调miR-217抑制肝癌细胞转移并增强细胞凋亡。
Comput Math Methods Med. 2023 Sep 27;2023:9793271. doi: 10.1155/2023/9793271. eCollection 2023.
3
[Retracted] HCV‑E2 inhibits hepatocellular carcinoma metastasis by stimulating mast cells to secrete exosomal shuttle microRNAs.[撤回]丙型肝炎病毒E2蛋白通过刺激肥大细胞分泌外泌体穿梭微小RNA抑制肝细胞癌转移。
Oncol Lett. 2024 May 8;28(1):301. doi: 10.3892/ol.2024.14434. eCollection 2024 Jul.
4
Retracted: The Relationship between Ultrasonographic Features of Hepatocellular Carcinoma and the Severity of Hepatocellular Carcinoma and the Expression of PTEN and Tg737.撤回：肝细胞癌的超声特征与肝细胞癌严重程度以及PTEN和Tg737表达之间的关系
J Healthc Eng. 2023 Oct 4;2023:9848563. doi: 10.1155/2023/9848563. eCollection 2023.
5
Retracted: Preliminary Evaluation of Artificial Intelligence-Based Anti-Hepatocellular Carcinoma Molecular Target Study in Hepatocellular Carcinoma Diagnosis Research.撤回：基于人工智能的抗肝细胞癌分子靶点研究在肝细胞癌诊断研究中的初步评估。
Biomed Res Int. 2023 Jul 12;2023:9850584. doi: 10.1155/2023/9850584. eCollection 2023.
6
Retracted: Analysis of Related Risk Factors of Microvascular Invasion in Hepatocellular Carcinoma.撤稿：肝细胞癌微血管侵犯相关危险因素分析
Comput Math Methods Med. 2023 Jul 19;2023:9808276. doi: 10.1155/2023/9808276. eCollection 2023.
7
Retracted: Identification and Validation of an Inflammatory Response-Related Polygenic Risk Score as a Prognostic Marker in Hepatocellular Carcinoma.撤回：鉴定和验证一种炎症反应相关多基因风险评分作为肝细胞癌的预后标志物
Dis Markers. 2023 Jul 26;2023:9809678. doi: 10.1155/2023/9809678. eCollection 2023.
8
Retracted: Value of 5-Hydroxymethylcytosine in HBV-Carrying High-Risk Hepatocellular Carcinoma Population: An Evaluation Based on Differential Analysis.撤稿：5-羟甲基胞嘧啶在乙肝病毒携带高危肝细胞癌人群中的价值：基于差异分析的评估
Comput Math Methods Med. 2023 Jun 28;2023:9829281. doi: 10.1155/2023/9829281. eCollection 2023.
9
Retracted: CDC20 May Serve as a Potential Biomarker-Based Risk Score System in Predicting the Prognosis of Patients with Hepatocellular Carcinoma.撤回：细胞周期蛋白依赖性激酶20（CDC20）可能作为基于生物标志物的风险评分系统用于预测肝细胞癌患者的预后。
Oxid Med Cell Longev. 2023 Aug 2;2023:9806284. doi: 10.1155/2023/9806284. eCollection 2023.
10
Retracted: microRNAs in hepatocellular carcinoma: carcinogenesis, progression, and therapeutic target.撤回：肝细胞癌中的微小RNA：致癌作用、进展及治疗靶点
Biomed Res Int. 2021 Feb 19;2021:1916343. doi: 10.1155/2021/1916343. eCollection 2021.
本文引用的文献
1
Risk Factors for Brain Metastasis of Hepatocellular Carcinoma.肝细胞癌脑转移的危险因素。
J Healthc Eng. 2022 Mar 9;2022:7848143. doi: 10.1155/2022/7848143. eCollection 2022.
Zotero 插件